The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study.

By B. Goodpaster, S. Park, Tamara B. Harris, Stephen B. Kritchevsky, M. Nevitt, A. Schwartz, Eleanor M. Simonsick, Fran Tylavsky, Marjolein Visser, Anne B. Newman. The journals of gerontology. Series A, Biological sciences and medical sciences, 2006

2,905 citations recorded by the source corpus.

Subfields: Geriatrics and Gerontology, Molecular Biology, Physiology

View Paper: https://www.semanticscholar.org/paper/51600a90bd7066ee2c339ac6381ba939745cbe8b

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Geriatrics and Gerontology

In Molecular Biology

In Physiology

Citations in the corpus

Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. (2011, background): “The Health and Body Composition Study, a longitudinal study of more than 3,000 older (age 70 – 79 y at baseline) has demonstrated the strong association of muscle mass with strength as well as the changing quality of skeletal muscle in late life (66).”
Sarcopenia With Limited Mobility: An International Consensus (2011, background): “Correlations between change in muscle mass and change in strength in older adults are inconsistent and not very robust.(28) One reason for this inconsistency is the infiltration into muscle by fat, which is a powerful predictor of future disability and mortality.”
Skeletal Muscle Power: A Critical Determinant of Physical Functioning In Older Adults (2012, background): “(21) examined the longitudinal changes (È3 yr) in muscle mass among 1880 relatively healthy older adults in the Health, Aging and Body Composition Study (mean initial age, 73.”
Sarcopenia: etiology, clinical consequences, intervention, and assessment (2009, background): “Another property of great interest to the study of sarcopenia is the mean attenuation coefficient [23, 117–119], which is computed within all of the muscle regions after a threshold is applied to exclude depots of fat embedded within each muscle group.”
Clinical definition of sarcopenia. (2014, background): “Sarcopenia is a syndrome characterized by progressive and generalized loss of skeletal muscle mass and strength with a risk of adverse outcomes such as physical disability, poor quality of life and death (8, 9).”
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes (2007, background): “However, determinants or risk factors for sarcopenia and low muscle strength in older adults have not been well identified (22).”
Sarcopenia, Dynapenia, and the Impact of Advancing Age on Human Skeletal Muscle Size and Strength; a Quantitative Review (2012, background): “Most people continue to gain fat mass in the eighth decade when muscle mass is decreasing (Goodpaster et al., 2006).”
Sarcopenia: European consensus on definition and diagnosis (2010, background): “Intramuscular and visceral fat increase with ageing while subcutaneous fat declines [18, 32, 33].”
Longitudinal study of muscle strength, quality, and adipose tissue infiltration. (2009, background): “The dramatically higher rates of strength loss relative to the loss of muscle mass in these older men and women is supported by our earlier report in this cohort that muscle strength declines at a more rapid rate than muscle mass as measured by DXA (4).”
AGE‐RELATED CHANGES IN THE STRUCTURE AND FUNCTION OF SKELETAL MUSCLES (2007, background): “the relative roles in the development of frailty of immutable age-related changes in the structure and function of skeletal muscles(15,42,49) and those attributable to a sedentary, low physical activity lifestyle.(17,50) For adult men and women, the ‘master athletes’ typify the most”